Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130

Vascular Medicine

Volumn 14, Issue 4, 2009, Pages 397-399

  Kreatsoulas, Catherine ^a   Anand, Sonia S ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; HUMAN; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SHORT SURVEY; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR PATENCY; VEIN BYPASS; VEIN GRAFT;

EID: 70350055332     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X09107006     Document Type: Short Survey

References (8)

1. Conte MS Lorenz TJ Bandyk DF Clowes AW Moneta GL Seely L. Design and rationale of the PREVENT III clinical trial. Edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovasc Surg 2005; 39: 15-23.
2. Stallones RA. The use and abuse of subgroup analysis in epidemiological research. Prev Med 1987; 16: 183-194.
3. Conte MS Bandyk DF Clowes AW. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006; 43: 742-751.
4. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 953-955.
5. Sturmer T Joshi M Glynn RJ Avorn J Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006; 59: 437-447.
6. Yusuf S Wittes J Probstfield J Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991; 266: 93-98.
7. Rothwell PM. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005; 365: 176-186.
8. Taylor AL Ziesche S Yancy C. for the African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351: 2049-2057.